Pten, tumorigenesis, and stem cell self-renewal.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16630811.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Self-renewal pathways crucial for maintaining stem cells are deregulated in cancer, raising the spectre that cancer therapies targeting such pathways might also ablate normal stem cells. As Yilmaz et al. (2006) report in a recent Nature paper, this may not be the case for the tumor suppressor protein Pten, which drives the self-renewal of normal hematopoietic stem cells and the formation of leukemia cells through different mechanisms.
Medical subject headings
- Cell Cycle
- Hematopoietic Stem Cells
- Leukemia, Myeloid, Acute
- PTEN Phosphohydrolase